Loading companies…
Loading companies…
United States · Biotech · AI
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $75M | Civilization Ventures — Role not disclosedEverbright Biofund — Role not disclosedForge Life Science Partners — Role not disclosedGodfrey Capital — Role not disclosedGoldcrest Capital — Role not disclosedMerck Global Health Innovation Fund — Role not disclosedPear VC — Role not disclosedPlayground Global — Role not disclosedRA Capital Management — Role not disclosedRegeneron Ventures — Role not disclosedWild Tree Ventures — Role not disclosed |